Repository logo

Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions.

Published version

Change log


Burr, Stephen P 
Costa, Ana SH 
Grice, Guinevere L 
Timms, Richard T 
Lobb, Ian T 


Hypoxia-inducible transcription factors (HIFs) control adaptation to low oxygen environments by activating genes involved in metabolism, angiogenesis, and redox homeostasis. The finding that HIFs are also regulated by small molecule metabolites highlights the need to understand the complexity of their cellular regulation. Here we use a forward genetic screen in near-haploid human cells to identify genes that stabilize HIFs under aerobic conditions. We identify two mitochondrial genes, oxoglutarate dehydrogenase (OGDH) and lipoic acid synthase (LIAS), which when mutated stabilize HIF1α in a non-hydroxylated form. Disruption of OGDH complex activity in OGDH or LIAS mutants promotes L-2-hydroxyglutarate formation, which inhibits the activity of the HIFα prolyl hydroxylases (PHDs) and TET 2-oxoglutarate dependent dioxygenases. We also find that PHD activity is decreased in patients with homozygous germline mutations in lipoic acid synthesis, leading to HIF1 activation. Thus, mutations affecting OGDHC activity may have broad implications for epigenetic regulation and tumorigenesis.



Aerobiosis, Cell Line, Genetic Testing, Germ-Line Mutation, Glutarates, HeLa Cells, Homozygote, Humans, Hydroxylation, Hypoxia-Inducible Factor 1, alpha Subunit, Ketoglutarate Dehydrogenase Complex, Lipoylation, Mitochondrial Proteins, Proline, Protein Stability, Sulfurtransferases

Journal Title

Cell Metab

Conference Name

Journal ISSN


Volume Title



Elsevier BV
Wellcome Trust (102770/Z/13/Z)
Medical Research Council (MC_UU_12022/6)
Wellcome Trust (101835/Z/13/Z)
MRC (unknown)
Wellcome Trust (100140/Z/12/Z)
Wellcome Trust (084957/Z/08/Z)
This work was supported by a Wellcome Trust Senior Clinical Research Fellowship to J.A.N. (102770/Z/13/Z), Wellcome Trust Principal Research Fellowship to P.J.L. (084957/Z/08/Z), and the Medical Research Council (A.S.H.C. and C.F.). The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (100140).